ASBP
Aspire Biopharma
ASBP
ASBP
14 hedge funds and large institutions have $17M invested in Aspire Biopharma in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
94% less capital invested
Capital invested by funds: $268M → $17M (-$251M)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.57M | |
| 3 | +$1.56M | |
| 4 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
+$1.56M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$703K |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$22.1M | |
| 3 | -$21M | |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$13.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$12.8M |